Myeloid Neoplasms
📧 Sign up to get email alerts when something new happens for Myeloid Neoplasms.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms [NA]
This document announces the recruitment for a randomized trial evaluating a mobile health exercise program for older adults with myeloid neo…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies [Phase 2]
Phase 2 pilot study to assess feasibility of using decitabine with filgrastim as post-transplant prophylaxis in children and young adults wi…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia [NA]
A clinical trial is evaluating how different hemoglobin threshold-specific packed red blood cell transfusion strategies affect quality of li…
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: Study of CPX-351 (VYXEOS) in Individuals < 22 Years With Secondary Myeloid Neoplasms [Phase 2]
Phase 2 clinical trial of CPX-351 (Vyxeos) in individuals under 22 with secondary myeloid neoplasms; study is currently active but not recru…
-
CLINICAL_TRIALS trial_result · 2025-10-08Clinical Trial Update: Futibatinib in Patients With Specific FGFR Aberrations [Phase 2]
Taiho Oncology reports a Phase 2 trial of futibatinib in patients with FGFR aberrations across advanced cancers. The study (NCT04189445) was…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-07-10Clinical Trial Update: CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients [Phase 2]
A Phase 2 clinical trial update evaluating CPX-351 (Vyxeos) or CLAG-M regimen for acute myeloid leukemia or other high-grade myeloid neoplas…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: The Myeloid Neoplasms Biology and Outcome Project
A prospective clinical study from University Hospital Heidelberg on the biology and outcomes of myeloid neoplasms. It is currently recruitin…
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms [Phase 2]
Phase 2 clinical trial update evaluating FCN-338 in combination with Azacitidine or chemotherapy for myeloid neoplasms. The study is sponsor…
-
CLINICAL_TRIALS trial_result · 2023-05-03Clinical Trial Update: A Mobile Health Exercise Intervention for Older Patients With Myeloid Neoplasms [NA]
This document reports a completed clinical trial evaluating a mobile health exercise program for older patients with myeloid neoplasms.